文献速递外周动脉疾病

慢性肢体威胁性缺血:腔内与保守治疗的死亡率差异倾向性评分匹配研究

The Difference in Mortality Rates Between Endovascular and Conservative Treatment for Patients with Chronic Limb-Threatening Ischemia: A Propensity Score Matching Study.
PubMed 文献 · Ann Vasc Surg · 2025-04-14

该回顾性注册研究纳入2016年1月至2023年9月北京世纪坛医院120例慢性肢体威胁性缺血患者,比较腔内治疗组(76例)与保守治疗组(44例)的死亡率。倾向性评分匹配后23对患者中,1年及3年死亡率组间无显著差异,年龄和吸烟状态为死亡的独立危险因素。

要点

  • 匹配后腔内组与保守组1年死亡率13.0%对17.4%(P=0.681),3年死亡率38.5%对36.0%(P=0.753),均无显著差异。
  • 匹配后Cox回归显示两组死亡风险无显著差异(HR 0.87,95%CI 0.14-5.55;P=0.880)。
  • 年龄和吸烟状态为死亡的独立危险因素(P<0.05)。

核心结论

  • 腔内治疗与保守治疗在1年和3年死亡率上无显著差异,并非所有慢性肢体威胁性缺血患者都需要血运重建才能达到与血运重建患者相似的免截肢生存,尽管保守治疗与腔内治疗在慢性肢体威胁性缺血患者中的疗效仍不明确。
  • 年龄和吸烟状态是与死亡风险升高相关的独立危险因素。

研究设计与样本

  • 该研究为观察性注册研究,回顾性分析2016年1月至2023年9月就诊于首都医科大学附属北京世纪坛医院血管外科的患者。
  • 共纳入120例慢性肢体威胁性缺血患者,其中腔内治疗组76例,保守治疗组44例,平均年龄(72±11)岁。
  • 采用倾向性评分匹配平衡两组协变量,匹配后得到23对患者。
  • 主要终点为全因死亡,中位随访时间33.5(21.3-45.0)个月。

主要发现

  • 总人群全因死亡率为32/120(26.7%)。
  • 匹配前单因素Cox回归显示年龄、性别、吸烟状态、Rutherford分级和Wounds、Ischemia、foot Infection评分与患者死亡率显著相关(P<0.05)。
  • 匹配前多因素Cox回归显示年龄和吸烟状态与患者死亡率独立相关(P<0.05)。
  • 匹配后腔内治疗组1年和3年死亡率分别为13.0%和38.5%,保守治疗组分别为17.4%和36.0%,1年(P=0.681)和3年(P=0.753)死亡率组间无统计学显著差异。
  • 匹配后Cox回归分析显示两组死亡风险无显著差异(HR 0.87,95%CI 0.14-5.55;P=0.880),免截肢生存两组间无显著差异(Breslow-Wilcoxon P=0.225)。

临床怎么用

  • 原文结论指出,并非所有慢性肢体威胁性缺血患者都需要血运重建才能达到与血运重建患者相似的免截肢生存,保守治疗与腔内治疗的疗效仍不明确。
  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The main objective of this study was to examine the impact of endovascular therapy versus conservative therapy on mortality rates among patients with chronic limb-threatening ischemia (CLTI). In addition, the outcomes of amputation-free survival (AFS) were also studied in both groups. METHODS: In this observational registry study, we retrospectively analyzed patients admitted to the Department of Vascular Surgery at Beijing Shijitan Hospital, Capital Medical University, from January 2016 to September 2023. Patients were categorized into an endovascular treatment group and a conservative treatment group. The primary endpoint was all-cause mortality. Propensity score matching was employed to balance covariates between the 2 groups, resulting in matched samples. We compared all-cause mortality between the groups and used univariate and multivariate Cox regression analyses to assess the impact of treatment on patient mortality both before and after matching. RESULTS: A total of 120 patients with a mean age of (72 ± 11) years were enrolled in this study, comprising 76 patients in the endovascular treatment group and 44 patients in the conservative treatment group. The median follow-up duration was 33.5 (21.3-45.0) months, during which the all-cause mortality rate was 32 out of 120 (26.7%). In terms of clinical characteristics, significant differences were observed between the 2 groups regarding age, hypertension, Rutherford classifications, and Wounds, Ischemia, and foot Infection scores (P < 0.05). However, no significant differences were found in gender, diabetes, coronary artery disease, smoking status, hyperlipidemia, prior ischemic stroke, or lesion site (P > 0.05). Before propensity score matching, univariate Cox regression analysis indicated that age, gender, smoking status, Rutherford classifications, and Wounds, Ischemia, and foot Infection scores were significantly associated with patient mortality (P < 0.05). Multivariate Cox regression analysis revealed that age and smoking status were independently associated with patient mortality (P < 0.05). Using propensity score matching, 23 pairs of patients were successfully matched between the 2 groups. The 1-year and 3-year mortality rates in the endovascular group were 13.0% and 38.5%, respectively, compared to 17.4% and 36.0% in the conservative treatment group. No statistically significant differences were observed in 1-year (P = 0.681) or 3-year (P = 0.753) mortality rates between the 2 groups. Cox regression analysis also showed no significant difference in the risk of death between the 2 groups (hazard ratio [HR] 0.87, 95% cofidence interval [CI] 0.14-5.55; P = 0.880). AFS did not differ significantly between the 2 groups (Breslow-Wilcoxon P = 0.225). CONCLUSION: No significant differences were observed in 1-year and 3-year mortality rates between endovascular treatment and conservative treatment, and not all patients with CLTI require revascularization to achieve an AFS that is similar to patients undergoing revascularization, although the efficacy of conservative versus endovascular treatment in CLTI patients is still unclear. Age and smoking status emerged as independent risk factors associated with an elevated risk of mortality.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Zhao Y, Ma Y, Jing Z, et al. The Difference in Mortality Rates Between Endovascular and Conservative Treatment for Patients with Chronic Limb-Threatening Ischemia: A Propensity Score Matching Study. Ann Vasc Surg. 2025. PMID: 40239762. doi:10.1016/j.avsg.2025.03.034

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。